Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
about
Metronidazole for the treatment of Tritrichomonas foetus in bulls.Improving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animals.Tg.rasH2 Mice and not CByB6F1 Mice Should Be Used for 28-Day Dose Range Finding Studies Prior to 26-Week Tg.rasH2 Carcinogenicity Studies.Progression of Serosal Vascular Proliferative Lesions to Hemangiosarcomas in the Uterus of the 26-Week Tg.rasH2 Mice Carcinogenicity Studies.Renal Tumors in 26-Week Tg.Rash2 Mice Carcinogenicity Studies.
P2860
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
@en
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
@nl
type
label
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
@en
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
@nl
prefLabel
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
@en
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
@nl
P2093
P2860
P356
P1476
Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
@en
P2093
Daniel Morton
Frank D Sistare
Nancy Bower
Oliver C Turner
Prashant R Nambiar
Zaher Radi
P2860
P304
P356
10.1177/0192623313502130
P407
P577
2013-08-21T00:00:00Z